150 related articles for article (PubMed ID: 17011825)
1. Evidence of recurrent gene fusions in common epithelial tumors.
Kumar-Sinha C; Tomlins SA; Chinnaiyan AM
Trends Mol Med; 2006 Nov; 12(11):529-36. PubMed ID: 17011825
[TBL] [Abstract][Full Text] [Related]
2. The discovery of common recurrent transmembrane protease serine 2 (TMPRSS2)-erythroblastosis virus E26 transforming sequence (ETS) gene fusions in prostate cancer: significance and clinical implications.
Shah RB; Chinnaiyan AM
Adv Anat Pathol; 2009 May; 16(3):145-53. PubMed ID: 19395877
[TBL] [Abstract][Full Text] [Related]
3. TMPRSS2:ETV4 gene fusions define a third molecular subtype of prostate cancer.
Tomlins SA; Mehra R; Rhodes DR; Smith LR; Roulston D; Helgeson BE; Cao X; Wei JT; Rubin MA; Shah RB; Chinnaiyan AM
Cancer Res; 2006 Apr; 66(7):3396-400. PubMed ID: 16585160
[TBL] [Abstract][Full Text] [Related]
4. Molecular genetic analyses of the TMPRSS2-ERG and TMPRSS2-ETV1 gene fusions in 50 cases of prostate cancer.
Winnes M; Lissbrant E; Damber JE; Stenman G
Oncol Rep; 2007 May; 17(5):1033-6. PubMed ID: 17390040
[TBL] [Abstract][Full Text] [Related]
5. Distinct classes of chromosomal rearrangements create oncogenic ETS gene fusions in prostate cancer.
Tomlins SA; Laxman B; Dhanasekaran SM; Helgeson BE; Cao X; Morris DS; Menon A; Jing X; Cao Q; Han B; Yu J; Wang L; Montie JE; Rubin MA; Pienta KJ; Roulston D; Shah RB; Varambally S; Mehra R; Chinnaiyan AM
Nature; 2007 Aug; 448(7153):595-9. PubMed ID: 17671502
[TBL] [Abstract][Full Text] [Related]
6. Characterization of TMPRSS2:ETV5 and SLC45A3:ETV5 gene fusions in prostate cancer.
Helgeson BE; Tomlins SA; Shah N; Laxman B; Cao Q; Prensner JR; Cao X; Singla N; Montie JE; Varambally S; Mehra R; Chinnaiyan AM
Cancer Res; 2008 Jan; 68(1):73-80. PubMed ID: 18172298
[TBL] [Abstract][Full Text] [Related]
7. Morphologic features of carcinomas with recurrent gene fusions.
Qi M; Li Y; Liu J; Yang X; Wang L; Zhou Z; Han B
Adv Anat Pathol; 2012 Nov; 19(6):417-24. PubMed ID: 23060067
[TBL] [Abstract][Full Text] [Related]
8. Chromosomal aberrations in solid tumors.
Chinnaiyan AM; Palanisamy N
Prog Mol Biol Transl Sci; 2010; 95():55-94. PubMed ID: 21075329
[TBL] [Abstract][Full Text] [Related]
9. [Frequent gene fusion in prostate cancer: clinical applications in diagnosis, prognosis and therapy].
Schmidt F; Scheble V; Mertz K; Perner S; Rubin MA
Dtsch Med Wochenschr; 2009 Jul; 134(28-29):1483-6. PubMed ID: 19572250
[TBL] [Abstract][Full Text] [Related]
10. Oncogenic gene fusions in epithelial carcinomas.
Prensner JR; Chinnaiyan AM
Curr Opin Genet Dev; 2009 Feb; 19(1):82-91. PubMed ID: 19233641
[TBL] [Abstract][Full Text] [Related]
11. The impact of translocations and gene fusions on cancer causation.
Mitelman F; Johansson B; Mertens F
Nat Rev Cancer; 2007 Apr; 7(4):233-45. PubMed ID: 17361217
[TBL] [Abstract][Full Text] [Related]
12. ETS gene fusions in prostate cancer: from discovery to daily clinical practice.
Tomlins SA; Bjartell A; Chinnaiyan AM; Jenster G; Nam RK; Rubin MA; Schalken JA
Eur Urol; 2009 Aug; 56(2):275-86. PubMed ID: 19409690
[TBL] [Abstract][Full Text] [Related]
13. Dissecting prostate carcinogenesis through ETS gene rearrangement studies: implications for anticancer drug development.
Attard G; Ang JE; Olmos D; de Bono JS
J Clin Pathol; 2008 Aug; 61(8):891-6. PubMed ID: 18495790
[TBL] [Abstract][Full Text] [Related]
14. CHCHD7-PLAG1 and TCEA1-PLAG1 gene fusions resulting from cryptic, intrachromosomal 8q rearrangements in pleomorphic salivary gland adenomas.
Asp J; Persson F; Kost-Alimova M; Stenman G
Genes Chromosomes Cancer; 2006 Sep; 45(9):820-8. PubMed ID: 16736500
[TBL] [Abstract][Full Text] [Related]
15. Recurrent gene fusions in prostate cancer: their clinical implications and uses.
Hessels D; Schalken JA
Curr Urol Rep; 2013 Jun; 14(3):214-22. PubMed ID: 23625457
[TBL] [Abstract][Full Text] [Related]
16. [Tumor-type specific translocations methods and indications for routine molecular pathology].
Gattenlöhner S; Müller-Hermelink HK
Verh Dtsch Ges Pathol; 2007; 91():154-9. PubMed ID: 18314609
[TBL] [Abstract][Full Text] [Related]
17. Two unique novel prostate-specific and androgen-regulated fusion partners of ETV4 in prostate cancer.
Hermans KG; Bressers AA; van der Korput HA; Dits NF; Jenster G; Trapman J
Cancer Res; 2008 May; 68(9):3094-8. PubMed ID: 18451133
[TBL] [Abstract][Full Text] [Related]
18. Simultaneously detection of genomic and expression alterations in prostate cancer using cDNA microarray.
Jiang M; Li M; Fu X; Huang Y; Qian H; Sun R; Mao Y; Xie Y; Li Y
Prostate; 2008 Oct; 68(14):1496-509. PubMed ID: 18366025
[TBL] [Abstract][Full Text] [Related]
19. MicroRNA expression profiling in prostate cancer.
Porkka KP; Pfeiffer MJ; Waltering KK; Vessella RL; Tammela TL; Visakorpi T
Cancer Res; 2007 Jul; 67(13):6130-5. PubMed ID: 17616669
[TBL] [Abstract][Full Text] [Related]
20. [Fusion genes and transcripts in neoplasia].
Kekeeva TV; Zavalishina LÉ; Frank GA; Zaletaev DV
Mol Biol (Mosk); 2011; 45(5):793-804. PubMed ID: 22393775
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
